| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/06/1999 | EP0912519A1 Quinoline sulfonamides as tnf inhibitors and as pde-iv inhibitors |
| 05/06/1999 | EP0912518A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 05/06/1999 | EP0912505A1 Il-8 receptor antagonists |
| 05/06/1999 | EP0912496A1 Inhibition of matrix metalloproteases by acetylene containing compounds |
| 05/06/1999 | EP0912494A1 Coumpounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 05/06/1999 | EP0912487A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors |
| 05/06/1999 | EP0912198A1 Immunoliposomes that optimize internalization into target cells |
| 05/06/1999 | EP0912196A1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization |
| 05/06/1999 | EP0912191A1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
| 05/06/1999 | EP0912189A1 Use of artichoke (cynara) extracts |
| 05/06/1999 | EP0912184A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 05/06/1999 | EP0912183A1 Heterocyclic compounds |
| 05/06/1999 | EP0912179A1 Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors |
| 05/06/1999 | EP0912106A1 Agent for increasing the production of/in breeding and production mammals |
| 05/06/1999 | EP0912091A1 Use of gaba uptake inhibitors as anti-tussive agents |
| 05/06/1999 | EP0912086A1 Regulation of alzheimer's disease related proteins and uses thereof |
| 05/06/1999 | EP0794953B1 Quinazoline derivatives |
| 05/06/1999 | EP0688320B1 Tricyclic benzodiazepins, their use and preparation |
| 05/06/1999 | EP0680333B1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 05/06/1999 | EP0667911B1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase |
| 05/06/1999 | EP0654272B1 Alimentary canal cell activator |
| 05/06/1999 | EP0582581B1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO[4,5-c]QUINOLIN-4-AMINES |
| 05/06/1999 | EP0570519B1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 05/06/1999 | CA2309135A1 N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors |
| 05/06/1999 | CA2308463A1 Cd8 as an inhibitor of the cellular immune system |
| 05/06/1999 | CA2308454A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | CA2308453A1 Method of reducing craving in mammals |
| 05/06/1999 | CA2308443A1 Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors |
| 05/06/1999 | CA2308327A1 Sarcodictyin and eleutherobin useful for stabilising microtubules |
| 05/06/1999 | CA2308069A1 Antagonists of gonadotropin releasing hormone |
| 05/06/1999 | CA2307953A1 Gene therapy for stimulation of angiogenesis |
| 05/06/1999 | CA2307952A1 4, 5-diaryloxazole compounds |
| 05/06/1999 | CA2307891A1 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 05/06/1999 | CA2307890A1 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 05/06/1999 | CA2307889A1 Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method |
| 05/06/1999 | CA2307830A1 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 05/06/1999 | CA2307826A1 Enhancement of morphogen activity |
| 05/06/1999 | CA2307661A1 Cyclopentene derivatives useful as antagonists of the motilin receptor |
| 05/06/1999 | CA2307595A1 Synthesis of swainsonine salts |
| 05/06/1999 | CA2307320A1 148 human secreted proteins |
| 05/06/1999 | CA2307178A1 Soluble mhc complexes and methods of use thereof |
| 05/06/1999 | CA2307030A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 05/06/1999 | CA2306082A1 Substituted 4-amino-thiazol-2-y compounds as cdks inhibitors |
| 05/06/1999 | CA2305258A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
| 05/05/1999 | CN1216063A IL-6 mutein |
| 05/05/1999 | CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors |
| 05/05/1999 | CN1215725A Triterpene derivatives and endothelin-receptor antagonists containing the same |
| 05/05/1999 | CN1215605A 'Shilongqingxue' Instant particle for treating hematencephalon |
| 05/05/1999 | CN1043231C Monohydrate of (E)-alpha-deoxy-alpha-(fluoro-methylene) cytidine |
| 05/05/1999 | CN1043230C Serotoninergic ergoline derivs. |
| 05/04/1999 | US5900436 Therapy for lipid metabolism disorders |
| 05/04/1999 | US5900434 Method for inhibiting the production of interleukin-1 or tumor necrosis factor-α by administering acanthoic acid |
| 05/04/1999 | US5900430 Cytokine inhibitors |
| 05/04/1999 | US5900429 Treating breast cancer in mammals by administering taxol or cisplatin to reduce tumor or cancer, then administering 2-methoxycarbonylaminobenzimidazole or pharmaceutical addition salts; anticarcinogenic/antitumor agents |
| 05/04/1999 | US5900428 Pharmacological use of AII-receptor antagonists |
| 05/04/1999 | US5900421 Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine |
| 05/04/1999 | US5900420 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
| 05/04/1999 | US5900360 Screening protein stabilizing agents (not congo red) by incubating cell containing conformationally defective protein, determining effective concentration to improve phenotype; treatment of cystic fibrosis, scrapie |
| 05/04/1999 | US5900257 Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists |
| 05/04/1999 | US5900255 Material for prevention and treatment of osteoporosis |
| 05/04/1999 | US5900247 Mucoadhesive pharmaceutical composition for the controlled release of active principles |
| 05/04/1999 | US5900235 Polypeptides |
| 05/04/1999 | US5900231 Cosmetic and/or dermatological skin treatment |
| 05/04/1999 | CA2184604C Bicyclic carbamates |
| 05/04/1999 | CA2078129C O6-benzylated guanine, guanosine and 2'- deoxyguanosine compounds possessing o6-alkylguanine-dna alkyltransferase depleting activity |
| 05/04/1999 | CA2058619C Process for the preparation of substituted isoflavone derivatives |
| 05/03/1999 | CA2252733A1 Sulfonamide-substituted benzopyran derivatives, processes for their preparation, their use as a medicament, and pharmaceutical preparations comprising them |
| 04/30/1999 | CA2249879A1 Synthetic core 2-like branched structures containing galnac-lewisx and neu5ac.alpha.2-3gal.beta.1-3galnac sequences as novel ligands for selectins |
| 04/29/1999 | WO1999020764A1 Robo: a family of polypeptides and nucleic acids involved in nerve guidance |
| 04/29/1999 | WO1999020643A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | WO1999020633A1 Benzoxazine derivatives, preparation and application in therapy |
| 04/29/1999 | WO1999020625A1 Novel polymorphic forms of cipamfylline |
| 04/29/1999 | WO1999020624A1 Bicyclic kinase inhibitors |
| 04/29/1999 | WO1999020622A1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors |
| 04/29/1999 | WO1999020621A1 ARYLPIPERAZINES AS SEROTONIN REUPTAKE INHIBITORS AND 5-HT1Dα ANTAGONISTS |
| 04/29/1999 | WO1999020616A1 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) |
| 04/29/1999 | WO1999020613A1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors |
| 04/29/1999 | WO1999020612A1 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 04/29/1999 | WO1999020611A1 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 04/29/1999 | WO1999020608A1 Isoquinolines as urokinase inhibitors |
| 04/29/1999 | WO1999020297A1 Prevention and treatment of adhesion formation |
| 04/29/1999 | WO1999020295A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/29/1999 | WO1999020293A1 Methods for treating hypercoagulable states or acquired protein c deficiency |
| 04/29/1999 | WO1999020279A1 Potentiation of pharmaceuticals |
| 04/29/1999 | WO1999020268A1 (3r,4r)-δ-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics |
| 04/29/1999 | WO1999020266A1 Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| 04/29/1999 | WO1999020264A1 Formulations and methods for reducing toxicity of antineoplastic agents |
| 04/29/1999 | WO1999020260A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 04/29/1999 | WO1999020121A2 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue |
| 04/29/1999 | WO1999006066A3 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 04/29/1999 | WO1999006033A3 An aqueous enteroclysis solution for the treatment of hepatic encephalopathy |
| 04/29/1999 | WO1999004775A9 Method of treating dopaminergic and gaba-nergic disorders |
| 04/29/1999 | WO1999003822A9 Bicyclic metabotropic glutamate receptor ligands |
| 04/29/1999 | WO1998042296A9 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 04/29/1999 | WO1998007715A9 Novel benzofuran-4-carboxamides |
| 04/29/1999 | DE19747063A1 New 3-substituted tetrahydropyridopyrimidinone derivatives |
| 04/29/1999 | DE19746612A1 New 2-substituted 1,2-benzisothiazole derivatives |
| 04/29/1999 | CA2307288A1 (3r,4r)-.delta.-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics |
| 04/29/1999 | CA2307199A1 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) |
| 04/29/1999 | CA2307114A1 Arylpiperazines as serotonin reuptake inhibitors and 5-ht1d.alpha. antagonists |